Trials / Sponsors / Suzhou Puhe Pharmaceutical Technology Co., LTD
Suzhou Puhe Pharmaceutical Technology Co., LTD
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | 2024-09-10 |
| Not Yet Recruiting | YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) | Phase 3 | 2023-05-01 |
| Unknown | Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR Treatment, Treatment Side Effects | Phase 1 / Phase 2 | 2018-03-30 |